figshare
Browse
Savendahl_Paed Safety 2_suppl material.pdf (1.31 MB)

Supplementary material for Long-term safety of growth hormone treatment in childhood: Two large observational studies NordiNet® IOS and ANSWER

Download (1.31 MB)
journal contribution
posted on 2021-01-15, 08:20 authored by Lars SävendahlLars Sävendahl, Michel Polak, Philippe Backeljauw, Joanne Blair, Bradley Miller, Tilman Rohrer, Anita Hokken-Koelega, Alberto Pietropoli, Nicky Kelepouris, Judith Ross
Supplementary material for the manuscript, "Long-term safety of growth hormone treatment in childhood: Two large observational studies NordiNet® IOS and ANSWER"

Funding

Novo Nordisk Health Care AG

History

Usage metrics

    Categories

    Keywords

    adverse eventschildhoodhuman growth hormonelong-term safetyneoplasms and malignanciesSAGhEEndocrinology

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC